Substrate processing apparatus and substrate processing method
The substrate processing apparatus addresses the challenge of impurity-induced degradation by implementing real-time impurity monitoring, ensuring high-quality chemical solutions are used, thereby reducing waste and improving process efficiency.
Patent Information
- Application Number
- KR1020250060330
- Authority / Receiving Office
- KR · KR
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-09
- Publication Date
- 2026-11-17
AI Technical Summary
Existing substrate processing systems lack real-time quality management of chemical solutions, leading to impurity-induced degradation and unnecessary waste due to time-based disposal, which affects process quality and efficiency.
A substrate processing apparatus equipped with a chemical solution inspection unit that measures impurity concentration in real time, controlling the supply of chemical solutions based on preset values to maintain quality and optimize consumption.
Real-time quality management of chemical solutions minimizes process defects and reduces waste by ensuring only high-quality solutions are used, enhancing substrate processing efficiency.
Smart Images

Figure PAT00005_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to a substrate processing apparatus, and more specifically, to a substrate processing apparatus and a substrate processing method capable of efficiently managing a chemical solution. Background Technology
[0002] In semiconductor manufacturing, various chemicals are used during the processes of cleaning or etching the surface of substrates. These processes effectively remove contaminants, metal impurities, fine particles, organic materials, and oxide films from the substrate surface, enabling the production of high-quality semiconductor devices. As these chemicals are critical factors determining the precision and quality of the process, they are often stored for a certain period of time in the field.
[0003] Generally, the chemical solution used in the semiconductor manufacturing process is stored in a tank and simultaneously circulated along a circulation line installed within the tank. During this process, the temperature of the solution is controlled and filtered. However, changes in the chemical composition of the solution during this process can lead to impurities. The occurrence of such impurities degrades the quality of the solution, which can cause problems with reduced process quality, such as non-uniformity in wafer surface treatment and the generation of residues. In particular, if the solution is IPA (isopropyl alcohol), IPA decomposes into acetone and water (H2O), which can cause defects on the substrate (W).
[0004] However, since the equipment supplying the chemical solution is not equipped with a device to analyze its quality, it is difficult to evaluate the quality in real time. Consequently, a method is used to prevent process quality degradation by discarding the stored solution whenever a preset time elapses. However, this method leads to unnecessary waste of the chemical solution. The problem to be solved
[0005] One objective of the present invention is to provide a substrate processing device and a substrate processing method capable of managing the quality of a chemical solution in real time.
[0006] In addition, the present invention has one objective of providing a substrate processing device and a substrate processing method capable of efficiently managing the consumption of a chemical solution.
[0007] In addition, the present invention has one objective of providing a substrate processing apparatus and a substrate processing method capable of efficiently processing a substrate.
[0008] The objectives of the present invention are not limited thereto, and other unmentioned objectives will be clearly understood by those skilled in the art from the description below. means of solving the problem
[0009] The present invention discloses an apparatus for processing a substrate. According to one embodiment of the present invention, the substrate processing apparatus comprises: a chamber for processing a substrate with a chemical solution; a chemical solution supply unit for supplying the chemical solution to the chamber; and a controller. The chemical solution supply unit comprises: a tank for storing the chemical solution; a chemical solution supply line connecting the tank and the chamber; and a chemical solution inspection unit installed in the tank for inspecting the chemical solution within the tank. The chemical solution inspection unit measures the concentration of impurities in the chemical solution, and the controller can control the chemical solution supply unit to stop supplying the chemical solution if the concentration of impurities inspected by the chemical solution inspection unit is greater than or equal to a preset value.
[0010] In addition, the present invention discloses a method for processing a substrate. According to one embodiment of the present invention, the substrate processing method includes an inspection step for inspecting a chemical solution supplied to a substrate; and a chemical solution supply step for supplying the chemical solution to the substrate to process the substrate, wherein the inspection step may not perform the chemical solution supply step if the concentration of impurities in the chemical solution is greater than or equal to a predetermined value when the concentration of impurities is measured. Effects of the invention
[0011] According to one embodiment of the present invention, the quality of the drug solution can be managed in real time.
[0012] In addition, according to one embodiment of the present invention, the consumption of the medicine solution can be efficiently managed.
[0013] In addition, according to one embodiment of the present invention, a substrate can be processed efficiently.
[0014] The effects of the present invention are not limited to the effects described above, and unmentioned effects will be clearly understood by those skilled in the art from this specification and the attached drawings. Brief explanation of the drawing
[0015] The various features and benefits of the non-limiting embodiments of this specification may become more apparent from a review of the detailed description in conjunction with the accompanying drawings. The accompanying drawings are provided for illustrative purposes only and should not be construed as limiting the claims. Unless expressly stated otherwise, the accompanying drawings are not to be drawn to scale. For clarity, various dimensions in the drawings may be exaggerated. FIG. 1 is a plan view schematically showing a substrate processing apparatus according to one embodiment of the present invention. Figure 2 is a schematic diagram showing one embodiment of the liquid treatment chamber of Figure 1. FIG. 3 is a schematic diagram showing one embodiment of a liquid medicine supply unit according to one embodiment of the present invention. Figure 4 is a schematic diagram showing the combination of a plurality of liquid treatment chambers and a chemical recovery unit. FIG. 5 is a schematic diagram showing one embodiment of a liquid medicine supply unit according to one embodiment of the present invention. Specific details for implementing the invention
[0016] Exemplary embodiments will now be described more fully with reference to the accompanying drawings. Exemplary embodiments are provided to ensure that the present disclosure is thorough and will fully convey its scope to those skilled in the art. To provide a complete understanding of the embodiments of the present disclosure, many specific details, such as examples of specific components, devices, and methods, are presented. It will be apparent to those skilled in the art that specific details are not necessary, that exemplary embodiments may be implemented in many different forms, and that neither should be interpreted as limiting the scope of the present disclosure. In some exemplary embodiments, known processes, known device structures, and known technologies are not described in detail.
[0017] The terms used herein are merely for describing specific exemplary embodiments and are not intended to limit exemplary embodiments. Singular expressions or expressions where singularity is not specified, as used herein, are intended to include plural expressions unless the context clearly indicates otherwise. The terms “comprising,” “comprising,” “having,” and “having” are open-ended and thus specify the presence of the mentioned features, components, steps, operations, elements, and / or components, and do not exclude the presence or addition of one or more other features, components, steps, operations, elements, components, and / or groups thereof. Method steps, processes, and operations in this specification are not to be interpreted as necessarily being performed in the specific order discussed or described unless the order of performance is specified. Additionally, additional or alternative steps may be selected.
[0018] When an element or layer is referred to as being "on," "connected," "combined," "attached," "adjacent," or "covering" another element or layer, it may be directly on, connected to, combined with, attached to, adjacent to, or covering said other element or layer, or intermediate elements or layers may exist. Conversely, when an element is referred to as being "directly on," "directly connected to," or "directly combined" with another element or layer, it should be understood that intermediate elements or layers do not exist. Throughout the specification, the same reference numerals refer to the same elements. The term "and / or" as used in the present invention includes all combinations and non-combinations of one or more of the listed items.
[0019] Although terms such as first, second, third, etc., may be used to describe various elements, regions, layers, and / or sections in the present invention, it should be understood that these elements, regions, layers, and / or sections are not limited by these terms. These terms are used merely to distinguish one element, region, layer, or section from another element, region, layer, or section. Accordingly, the first element, first region, first layer, or first section discussed below may be referred to as the second element, second region, second layer, or second section without departing from the teachings of the exemplary embodiments.
[0020] Spatially relative terms (e.g., "below," "under," "lower," "above," "top," etc.) may be used for convenience of explanation to describe the relationship between one element or feature and another element(s) or feature(s) as illustrated in the drawings. It should be understood that spatially relative terms are intended to include not only the orientations illustrated in the drawings but also other orientations of the device in use or operation. For example, if the device in the drawings is inverted, elements described as "below" or "under" other elements or features will be oriented "above" other elements or features. Thus, the term "below" may include both upper and lower orientations. The device may be oriented differently (rotated 90 degrees or in a different orientation), and the spatially relative descriptive terms used in the present invention may be interpreted accordingly.
[0021] It should be understood that there may be some inaccuracy when the terms "identical" or "same" are used in the description of the embodiments. Therefore, if one element or value is referred to as identical to another element or value, it should be understood that said element or value is identical to another element or value within a manufacturing or operating tolerance (e.g., ±10%).
[0022] Where the words “approximately” or “substantially” are used in this specification with respect to figures, it should be understood that such figures include manufacturing or operational tolerances (e.g., ±10%) of the figures mentioned. Additionally, where the words “generally” and “substantially” are used with respect to geometric forms, it should be understood that while geometric accuracy is not required, freedom of form (latitude) is within the scope of disclosure.
[0023] Unless otherwise defined, all terms used in the present invention (including technical and scientific terms) have the same meaning as generally understood by those skilled in the art to which the exemplary embodiments belong. Furthermore, terms, including those defined in commonly used dictionaries, should be interpreted as having a meaning consistent with that meaning in the context of the relevant technology, and should not be interpreted in an ideal or overly formal sense unless explicitly defined in the present invention.
[0024] In this embodiment, a wafer is used as an example of the object to be processed. However, the technical concept of the present invention may be applied to devices used for processing other types of substrates besides wafers as the object to be processed.
[0026] Hereinafter, embodiments of the present invention will be described with reference to the attached drawings.
[0027] FIG. 1 is a plan view schematically showing a substrate processing apparatus according to one embodiment of the present invention. Referring to FIG. 1, the substrate processing apparatus includes an index module (10), a processing module (20), and a controller (30). According to one embodiment, the index module (10) and the processing module (20) are arranged along one direction. Hereinafter, the direction in which the index module (10) and the processing module (20) are arranged is referred to as the first direction (92), the direction perpendicular to the first direction (92) when viewed from above is referred to as the second direction (94), and the direction perpendicular to both the first direction (92) and the second direction (94) is referred to as the third direction (96).
[0028] The index module (10) returns the substrate (W) from the container (80) containing the substrate (W) to the processing module (20), and receives the substrate (W) that has been processed in the processing module (20) back into the container (80). The longitudinal direction of the index module (10) is provided as a second direction (94). The index module (10) has a load port (12) and an index frame (14). The load port (12) is located on the opposite side of the processing module (20) relative to the index frame (14). The container (80) containing the substrates (W) is placed in the load port (12). Multiple load ports (12) may be provided, and multiple load ports (12) may be arranged along the second direction (94).
[0029] For the container (80), a sealed container such as a Front Open Unified Pod (FOUP) may be used. The container (80) may be placed in the load port (12) by a transport means (not shown) such as an overhead transfer, an overhead conveyor, or an automatic guided vehicle, or by a worker.
[0030] An index robot (120) is provided in the index frame (14). A guide rail (140) is provided within the index frame (14) with a longitudinal direction in the second direction (94), and the index robot (120) can be provided to be movable on the guide rail (140). The index robot (120) includes a hand (122) on which a substrate (W) is placed, and the hand (122) can be provided to move forward and backward, rotate about the third direction (96) as an axis, and move along the third direction (96). A plurality of hands (122) are provided spaced apart in the vertical direction, and the hands (122) can move forward and backward independently of each other.
[0031] The processing module (20) includes a buffer chamber (200), a return chamber (300), a process chamber (400), and a chemical supply unit (500).
[0032] The buffer chamber (200) provides a space where substrates (W) introduced into the processing module (20) and substrates (W) removed from the processing module (20) temporarily stay. The buffer chamber (200) is equipped with a plurality of buffers (220) on which substrates (W) are temporarily placed. The buffers (220) may be spaced apart from each other along the third direction (96). The front face and rear face of the buffer chamber (200) are open. The front face is the side facing the index module (10), and the rear face is the side facing the return chamber (300). The index robot (120) can access the buffer chamber (200) through the front face, and the return robot (320) can access the buffer chamber (200) through the rear face.
[0033] The return chamber (300) returns the substrate (W) between the buffer chamber (200) and the liquid processing chamber (400). The return chamber (300) may be provided with its length direction in the first direction (92). The buffer chamber (200) may be positioned between the index module (10) and the return chamber (300). Multiple liquid processing chambers (400) may be provided and may be positioned on the side of the return chamber (300). The liquid processing chamber (400) and the return chamber (300) may be positioned along the second direction (94). The buffer chamber (200) may be located at one end of the return chamber (300).
[0034] According to one example, liquid treatment chambers (400) are each placed on both sides of the return chamber (300). On each side of the return chamber (300), the liquid treatment chambers (400) may be provided in an AXB arrangement (where A and B are each 1 or a natural number greater than 1) along the first direction (92) and the third direction (96).
[0035] The return chamber (300) has a return robot (320). A guide rail (340) is provided within the return chamber (300) in a longitudinal direction in the first direction (92), and the return robot (320) can be provided to be movable on the guide rail (340). The return robot (320) includes a hand (322) on which a substrate (W) is placed, and the hand (322) can be provided to move forward and backward, rotate about the third direction (96) as an axis, and move along the third direction (96). A plurality of hands (322) are provided spaced apart in the vertical direction, and the hands (322) can move forward and backward independently of each other.
[0036] The process chamber (400) receives a chemical solution from the chemical solution supply unit (500) and supplies the chemical solution onto the substrate (W) to perform a process of liquid treatment on the substrate (W). Below, the process chamber (400) is described as a liquid treatment chamber.
[0037] FIG. 2 is a schematic diagram showing one embodiment of the liquid treatment chamber (400) of FIG. 1. Referring to FIG. 2, the liquid treatment chamber (400) has a housing (410), a cup body (420), a support unit (440), a nozzle unit (460), and a lifting unit (480).
[0038] The housing (410) is generally provided in a rectangular shape. The cup body (420), support unit (440), and nozzle unit (460) are placed within the housing (410).
[0039] The cup body (420) has a processing space with an open top, and the substrate (W) is liquid-processed within the processing space. The support unit (440) supports the substrate (W) within the processing space. The nozzle unit (460) supplies a chemical solution onto the substrate (W) supported by the support unit (440). The chemical solution is provided in multiple types and can be supplied sequentially onto the substrate (W). The lifting unit (480) adjusts the relative height between the cup body (420) and the support unit (440).
[0040] According to one example, the cup body (420) has a plurality of recovery containers (422, 424, 426). Each of the recovery containers (422, 424, 426) has a recovery space for recovering the chemical solution used in the substrate treatment. Each of the recovery containers (422, 424, 426) is provided in a ring shape that surrounds the support unit (440). During the liquid treatment process, the chemical solution scattered by the rotation of the substrate (W) flows into the recovery space through the inlets (422a, 424a, 426a) of each recovery container (422, 424, 426). According to one example, the cup body (420) has a first recovery container (422), a second recovery container (424), and a third recovery container (426). The first recovery container (422) is positioned to surround the support unit (440), the second recovery container (424) is positioned to surround the first recovery container (422), and the third recovery container (426) is positioned to surround the second recovery container (424). The liquid medicine can be introduced into the first recovery container (422) through the first inlet (422a), into the first recovery container (424) through the second inlet (424a), and into the third recovery container (422) through the third inlet (422a). The second inlet (424a) is located above the first inlet (422a), and the third inlet (426a) can be located above the second inlet (424a).
[0041] The support unit (440) has a support plate (442) and a drive shaft (444). The upper surface of the support plate (442) is generally provided in a circular shape and may have a diameter larger than that of the substrate (W). A support pin (442a) is provided in the central part of the support plate (442) to support the rear surface of the substrate (W), and the upper end of the support pin (442a) is provided to protrude from the support plate (442) so that the substrate (W) is spaced a certain distance from the support plate (442). A chuck pin (442b) is provided at the edge of the support plate (442). The chuck pin (442b) is provided to protrude upward from the support plate (442) and supports the side of the substrate (W) so that the substrate (W) does not detach from the support unit (440) when the substrate (W) is rotated. The drive shaft (444) is driven by the drive unit (446) and is connected to the center of the bottom surface of the substrate (W), and rotates the support plate (442) around its center axis.
[0042] The nozzle unit (460) has a first nozzle (462) and a second nozzle (464). The first nozzle (462) supplies a chemical solution onto a substrate (W). In one example, the chemical solution may be isopropyl alcohol (IPA). Additionally, the chemical solution may be a liquid at a temperature higher than room temperature. The second nozzle (464) may supply water onto the substrate (W). The water may be pure water or deionized water.
[0043] The first nozzle (462) and the second nozzle (464) are each supported on different arms (461), and these arms (461) can be moved independently. Optionally, the first nozzle (462) and the second nozzle (464) can be mounted on the same arm and moved simultaneously.
[0044] Optionally, the liquid supply unit (500) may be provided with one or more additional nozzles in addition to the first nozzle (462) and the second nozzle (464). The additional nozzles may supply a different type of liquid to the substrate. For example, the different type of liquid may be an acid solution or a base solution for removing foreign matter from the substrate.
[0045] The lifting unit (480) moves the cup body (420) in the up and down direction. The relative height between the cup body (420) and the substrate (W) is changed by the up and down movement of the cup body (420). Accordingly, the recovery container (422, 424, 426) for recovering the liquid is changed according to the type of liquid supplied to the substrate (W), so the liquids can be recovered separately. Unlike the above, the cup body (420) is fixedly installed, and the lifting unit (480) can move the support unit (440) in the up and down direction.
[0046] The liquid supply unit (500) supplies the liquid to the first nozzle (462). The liquid supply unit (500) may include a tank (510), a liquid inspection unit (520), a circulation line (530), and a liquid supply line (550).
[0047] The tank (510) provides a storage space for storing the liquid medicine. Additionally, a circulation line (530) is installed in the tank (510). The circulation line (530) provides a path for the liquid medicine to circulate. Accordingly, the liquid medicine stored in the tank (510) can circulate along the circulation line (530). A filter (531) and a heater (533) may be installed in the circulation line (530). The filter (531) can filter the liquid medicine, and the heater (533) can heat the liquid medicine. As the liquid medicine circulates through the tank (510) and the circulation line (530), it is heated to a preset temperature and can be supplied to the first nozzle (462). In one example, the liquid medicine may be isopropyl alcohol.
[0048] Additionally, a replenishment line (511) and a discharge line (513) may be installed in the tank (510). The replenishment line (511) connects the liquid supply source (511a) and the tank (510). Liquid stored in the liquid supply source (511a) can be supplied to the tank (510) along the replenishment line (511). The discharge line (513) can drain the liquid stored in the tank (510) to the outside.
[0049] A chemical liquid inspection unit (520) inspects the chemical liquid stored in a tank (510). The chemical liquid inspection unit (520) may be installed in the tank (510). The chemical liquid inspection unit (520) may include an inspection line (521) and an inspector (523). The inspection line (521) is installed in the tank (510) and provides a path for the chemical liquid stored in the tank (510) to be transferred to the inspector (523). The chemical liquid stored in the tank (510) flows into the inspector (523) along the inspection line (521), and the inspector (523) can inspect the chemical liquid. According to one example, the inspector (523) can measure the concentration of impurities in the chemical liquid. The impurities may be organic and / or inorganic (H2O). Additionally, the impurities may be particles precipitated from the chemical liquid. The inspector (523) may measure impurities contained in the liquid medicine through a spectroscopic inspection method. According to one example, the inspector (523) may include a Fourier transform infrared spectrometer (FT-IR) and / or a Fourier transform near-infrared spectrometer (FT-NIR). Here, Fourier transform infrared spectrometry (FT-IR) is an analytical method that measures energy absorption due to molecular vibration or rotation by irradiating a sample with infrared light, and is used to determine molecular structure. The inspector (523) may obtain a spectroscopic spectrum by irradiating infrared or near-infrared light onto the liquid medicine and measure the concentration of impurities in the liquid medicine by applying a Fourier transform to the spectroscopic spectrum. Additionally, the inspector (523) may further include a liquid particle counter that measures the number of particles in the liquid medicine using a light scattering method (laser scattering method).
[0050] The inspector (523) may be provided to provide real-time feedback of the inspection results. According to one example, the inspector (523) may be connected to the controller (30) via an electronic communication link (wired or wireless) and may transmit the measurement results to the controller (30).
[0051] The liquid supply line (550) may be installed in the circulation line (530). The liquid supply line (550) may be formed by branching off from the circulation line (530). However, it is not limited thereto, and the liquid supply line (550) may also be installed directly in the tank (510). The liquid supply line (550) is connected to the first nozzle (462). The liquid stored in the tank (510) and circulated along the circulation line (530) may be supplied to the first nozzle (462) along the liquid supply line (550).
[0052] The controller (30) may be provided with a process controller consisting of a microprocessor (computer) that executes control of the substrate processing device, a user interface consisting of a keyboard for an operator to perform command input operations to manage the substrate processing device, a display for visualizing and displaying the operating status of the substrate processing device, a control program for executing processing in the substrate processing device under the control of the process controller, and a memory unit storing a program for executing processing in each component according to various data and processing conditions, i.e., a processing recipe. Additionally, the user interface and the memory unit may be connected to the process controller. The processing recipe may be stored in a storage medium within the memory unit, and the storage medium may be a hard disk, a portable disk such as a CD-ROM or DVD, or a semiconductor memory such as a flash memory.
[0053] Hereinafter, a method for processing a substrate is described. The substrate processing method described below can be performed by a substrate processing device described with reference to FIGS. 1 to 3. Accordingly, the substrate processing method according to one embodiment is described below by citing the reference numerals shown in FIGS. 1 to 3 as they are. In addition, the substrate processing method described below can be performed by a controller (30) controlling the components included in the substrate processing device described above.
[0054] FIG. 4 is a flowchart illustrating a substrate processing method according to an embodiment of the present invention. Referring to FIG. 4, the substrate processing method may include a chemical solution preparation step (S100) and a chemical solution supply step (S200).
[0055] The chemical solution preparation step (S100) is a step of storing the chemical solution in a tank (510), circulating it through a circulation line (530) to adjust the temperature of the chemical solution, and removing impurities from the chemical solution. The chemical solution preparation step (S100) can be performed after the chemical solution supply step (S200) has started, or even during the chemical solution supply step. That is, the chemical solution preparation step (S100) can be performed regardless of whether the chemical solution is being supplied.
[0056] The drug solution preparation step (S100) includes a drug solution inspection step (S110), and the quality of the drug solution can be inspected in the drug solution inspection step (S110).
[0057] The chemical solution inspection step (S110) is a step of inspecting the chemical solution stored in the tank (510). In the chemical solution inspection step (S110), the concentration of impurities in the chemical solution is measured. FIG. 6 is a flowchart illustrating an embodiment of the chemical solution inspection step. Referring to FIG. 6, the chemical solution stored in the tank (510) is supplied to an inspector (523) through an inspection line (521) (S111). The concentration of impurities in the chemical solution is measured at the inspector (523) (S112). The impurities may be organic, inorganic, and / or particles. According to one example, the chemical solution is isopropyl alcohol (IPA), and the impurities may be substances decomposed from IPA or substances generated therefrom. When IPA (C2H5OH) is stored for a long period, IPA may gradually decompose to produce acetone (CH3COCH3), which is an organic substance, and water (H2O), which is an inorganic substance. Additionally, acetone can aggregate with other organic substances, metal ions, or fine particles within the IPA to form particles. Fig. 5 is a graph showing the concentration of acetone and the number of particles within the IPA according to the storage time of the IPA. Referring to Fig. 5, it can be seen that the concentration of acetone and the number of particles have the same trend. That is, it can be seen that the generation of acetone causes the generation of particles within the IPA. This process can be accelerated as the temperature of the IPA increases, causing the reaction rate to rise. The inspector (523) can measure at least one of these acetone, water, and particles. The concentration of impurities measured by the inspector (523) is transmitted to the controller (30) in real time, and the controller (30) can control the substrate processing device by comparing the measured concentration of impurities with a preset value. That is, the controller (30) can determine whether the impurities are detected at a concentration higher than the preset concentration (S113). According to one example, if the measured concentration of impurities is greater than a preset value, the controller (30) can control the substrate processing device so as not to perform the chemical solution supply step (S200) (S114).Afterward, the liquid medicine stored in the tank (510) is drained through the discharge line (513), and new liquid medicine is replenished from the liquid medicine supply source (511a) and the replenishment line (511) (S115). Afterward, the process of measuring the concentration of impurities in the liquid medicine is repeated by returning to S111. If the measured concentration of impurities is greater than a preset value, the inspector (523) can provide feedback on the concentration of impurities in real time during this process until the concentration becomes less than the preset value. The controller (30) can control the liquid medicine supply unit (500) to perform the liquid medicine supply step (S200) again after the concentration of impurities in the liquid medicine becomes less than the preset value. According to another example, if the measured concentration of impurities is greater than the preset value, all the liquid medicine stored in the tank (510) and circulating through the circulation line (530) can be drained and replaced with new liquid medicine (S116). Afterward, return to S111 to measure the concentration of impurities in the liquid medicine. If the concentration of impurities is less than a preset value as a result of the inspection by the detector (523), the liquid medicine supply step (S200) may be performed.
[0058] The chemical solution supply step (S200) is a step of supplying a chemical solution to a liquid treatment chamber (400) and treating the substrate (W) with the supplied chemical solution. In the chemical solution supply step (S200), the first nozzle (462) supplies the chemical solution to the substrate (W), and the support unit (440) rotates the substrate (W). The chemical solution supplied onto the substrate (W) spreads to the front surface of the substrate (W) along with the rotation of the substrate (W), allowing the entire substrate (W) to be treated.
[0059] Generally, the chemical solution supply unit (500) is often not equipped with a means to measure impurities in the chemical solution in real time. As a result, when the chemical solution is stored for a long period, it may be used without identifying the impurities generated in the chemical solution, which may lead to process defects. In addition, if process defects occur, all the chemical solution in the tank (510) must be discharged, resulting in waste of the chemical solution. In particular, if the chemical solution is IPA, the IPA gradually decomposes to produce acetone and water, which may cause defects during substrate processing.
[0060] However, according to one embodiment of the present invention, impurities in the stored chemical solution can be inspected in real time. By evaluating the quality of the chemical solution in real time, if the quality is below a standard, the chemical solution can be managed to satisfy the standard. By managing the quality of the chemical solution in real time in this way, defects occurring on the substrate (W) can be minimized, thereby improving the quality of the process. In addition, since the amount of discarded chemical solution can be reduced, the chemical solution can be managed efficiently, thereby increasing the efficiency of substrate processing.
[0061] In the example described above, the inspection device (523) was explained as an example of inspecting impurities using light. However, it is not limited to this, and any means capable of inspecting impurities is sufficient.
[0062] In addition, the example described above explained the case where only acetone is present as an organic impurity in the IPA solution. However, this is not limited to this, and diacetone alcohol (C6H 12 It may be O2, Diacetone Alcohol (DAA), Acetic Acid, or Isopropyl Acetate.
[0063] Additionally, in the example described above, stopping the supply of the chemical solution when impurities are detected above a set concentration (S114) was explained as an example. However, this is not limited thereto, and if the supply of the chemical solution has not been initiated, the control of the impurity concentration in the chemical solution (S115) or the replacement of the chemical solution (S116) can be performed without stopping the supply of the chemical solution (S114).
[0064] The above detailed description is illustrative of the present invention. Furthermore, the foregoing describes preferred embodiments of the present invention, and the present invention may be used in various other combinations, modifications, and environments. That is, modifications or alterations are possible within the scope of the concept of the invention disclosed herein, the scope equivalent to the disclosed content, and / or the scope of the art or knowledge. The described embodiments describe the best state for implementing the technical concept of the present invention, and various modifications required in specific fields of application and uses of the present invention are possible. Accordingly, the above detailed description of the invention is not intended to limit the present invention to the disclosed embodiments. Furthermore, the appended claims should be interpreted as including other embodiments. Explanation of the symbols
[0065] 400: Liquid treatment chamber 500: Liquid supply unit 510: Tank 511: Replacement Line 513: Discharge line 520: Drug Solution Inspection Unit 523: Checker 530: Circular line 550: Liquid supply line
Claims
Claim 1 A substrate processing apparatus comprising: a chamber for processing a substrate with a chemical solution; a chemical solution supply unit for supplying the chemical solution to the chamber; and a controller, wherein the chemical solution supply unit comprises: a tank for storing the chemical solution; a chemical solution supply line connecting the tank and the chamber; and a chemical solution inspection unit installed in the tank for inspecting the chemical solution within the tank, wherein the chemical solution inspection unit measures the concentration of impurities in the chemical solution, and the controller controls the chemical solution supply unit to stop supplying the chemical solution when the concentration of impurities inspected by the chemical solution inspection unit is greater than or equal to a preset value. Claim 2 In claim 1, the above-mentioned impurity is an organic material in the substrate processing device. Claim 3 In paragraph 2, the above liquid supply unit comprises: a circulation line installed in the tank and providing a circulation path through which the liquid stored in the tank circulates; and a substrate processing device including a heater installed in the circulation line. Claim 4 In paragraph 3, the above impurity is a substrate processing device further comprising particles. Claim 5 A substrate processing device according to claim 1, wherein the liquid supply unit further comprises a discharge line for discharging the liquid in the tank; and a replenishment line for replenishing the liquid in the tank, and the controller controls the replenishment and discharge of the liquid so that the concentration of impurities in the liquid stored in the tank becomes less than a preset value. Claim 6 In claim 1, the above chemical solution is a substrate processing device in which is isopropyl alcohol (IPA). Claim 7 A method for processing a substrate, comprising: an inspection step for inspecting a chemical solution supplied to a substrate; and a chemical solution supply step for supplying the chemical solution to a substrate to process the substrate, wherein in the inspection step, the concentration of impurities in the chemical solution is measured, and if the concentration of impurities is greater than or equal to a predetermined value, the chemical solution supply step is not performed. Claim 8 A substrate treatment method according to claim 7, wherein the above chemical solution is IPA (isopropyl alcohol) and the above impurity is an organic material. Claim 9 In claim 8, the inspection step involves inspecting a heated chemical solution, and the impurities are a substrate treatment method comprising particles. Claim 10 A substrate processing method according to claim 9, wherein if the concentration of impurities in the drug solution measured in the inspection step is greater than or equal to the preset value, the drug solution is discharged and refilled until the concentration of impurities becomes less than the preset value, and then the drug solution supply step is performed.
